Figure 1
From: Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents
Relationship between body surface area (BSA) and drug clearance for all six drugs (for irinotecan, apparent clearance corresponding to SN-38 was considered). R2 values indicate the contribution of BSA to the interindividual variability in clearance.
